Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate change and update

2nd Dec 2011 07:00

CERES MEDIA INTERNATIONAL PLC ("Ceres" or the "Company" or the "Group") Directorate change and update Board Changes

The board announce that due to ill health, Matthew Howes has resigned as Finance Director of the Company with immediate effect. The board would like to thank Matthew for his contribution to the Group especially throughout the recent AIM admission process. The board wish Mr Howes well in the future.

A financial controller has been appointed to the Company effective 5 December 2011, who will report directly to the board.

Leslie Barber, currently a non-executive director of the Company will become an executive director with immediate effect.

Update

Further to the update provided in the Chairman's statement in the preliminary results notified 28 October 2011 the Company continues to experience slower than expected uptake of its product range and is working with its end-users and manufactures to refine its product offerings. The Company has noted continued interest and awareness in its product from end users. The Company has further expanded its distribution network in the UK, Europe and North America.

In light of the materially poorer than anticipated sales to date the Company is actively reviewing the current sales strategy. The Group has recently strengthened the sales team with the appointment of 2 new salesmen. The board also announces that Cliff Barry who was director of sales has left the Group.

A further announcement will be made in due course.

For further information, please contact:

Ceres Media International PLC Tel: 020 3178 5622 Leslie Barber Nominated Adviser Tel: 020 7148 7900 Cairn Financial Advisers LLP Jo Turner / Liam Murray Broker Tel: 020 3002 2070 First Columbus LLP

Chris Crawford / Kelly Gardiner

Financial PR Tel: 020 7556 1063 De Facto Financial Mike Wort / Anna Dunphy

XLON

Related Shares:

OptiBiotix Health
FTSE 100 Latest
Value8,809.74
Change53.53